Catégorie : Blog

[Press Release]Accelarated Scientific Advise from European Medicines Adgency EMA for Xav-19 Market Authorisation

July 8, 2021. # Download our press release (english version) # Télécharger notre communiqué de presse (version française)

[Newsletter] XENONEWS

Summer 2021. >> Official Xenothera newsletter /Lettre d’information officielle de Xenothera << # Download our newsletter (english version) # Télécharger notre newsletter (version française)

[Press Alert] XENOTHERA signs a pre-order contract of its anti-covid treatment with the French government

May 11, 2021. # Download our press information (english version) # Télécharger notre information presse (version française)

[Newsletter] XENONEWS

May 2021 >> Official Xenothera newsletter /Lettre d’information officielle de Xenothera << # Download our newsletter (english version) # Télécharger notre newsletter (version française)

[Press Alert] XENOTHERA And Its Partner Excelya Announce the Recruitment of the First Patient in The EUROXAV Clinical Trial of its COVID Treatment XAV-19

May 3, 2021. # Download our press information (english version) # Télécharger notre information presse (version française)

[Newsletter] XENONEWS

April 2021 >> Official Xenothera newsletter /Lettre d’information officielle de Xenothera << # Download our newsletter (english version) # Télécharger notre newsletter (version française)

[Press Release] Completion of patients’ enrolment in the POLYCOR clinical trial promoted by the Nantes University Hospital

April 21, 2021. # Download our press release (english version) # Télécharger notre communiqué de presse (version française)

[Newsletter] XENONEWS

February 2021 >> Official Xenothera newsletter /Lettre d’information officielle de Xenothera << # Download our newsletter (english version) # Télécharger notre newsletter (version française)

[Newsletter] XENONEWS

January 2021 >> Official Xenothera newsletter /Lettre d’information officielle de Xenothera << # Télécharger notre newsletter (version française) # Download our newsletter(english version)

[Press Release] XAV-19 : validation of the first dose of anti-Covid treatment of XENOTHERA

November 12, 2020. # Download our press release (english version) # Télécharger notre communiqué de presse (version française)